Investment Objective and Approach

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

The fund follows a focused sectoral investment approach, specifically targeting the pharmaceutical and healthcare industry. Benchmark: Nifty Healthcare TRI # Additional Benchmark: Nifty 50 TRI. This specialized strategy aims to capitalize on the growth potential within the healthcare ecosystem, including pharmaceutical companies, healthcare service providers, and related businesses.

Key Investment Features:

- Minimum SIP Amount: ₹500 for the SIP (Systematic Investment Plan) option

- Minimum Lumpsum Investment: ₹5,000 for the lump sum option

- Fund Launch Date: 14 May 2018

- Latest NAV (as of July 7, 2025): ₹17.978

- Current AUM: ₹220.85 Crores

Fund Managers

The fund is managed by an experienced team of professionals:

Current Fund Managers:

- Dhimant Shah: currently managed by its fund managers Dhimant Shah and Rohan Korde - Mr. Shah is a B.Com (H) and Chartered Accountant.

- Rohan Korde: Mr. Rohan Korde (Since 08-Nov-21) - Mr. Korde is a Masters in Management Studies (Finance), Bachelor of Commerce... Prior to joining ITI Mutual Fund, he was associated with The Investment Trust Of India Ltd, Simto Investment Company Ltd, ProAlpha Systematic Capital, Heritage India Advisors Ltd and Reliance Capital Asset Management Ltd

Additional team members include:

- Pratibh Agarwal: Mr. Pratibh Agarwal (Since 29-Apr-22)

- Hetal Gada: Ms. Hetal Gada (Since 29-Apr-22)

About the Fund House (AMC)

ITI Mutual Fund was established in 2018 to offer the best investment solutions to investors for wealth generation over the long-term. It boasts of thoughtful and investor-centric investment solutions backed by a highly experienced team of researchers and investment managers.

Key Facts about ITI AMC:

- Establishment Year: 2018

- Promoter: The Investment Trust of India Ltd

- Network: 29 branches in India with more than 196 employees

- Total AUM: Rs. 6396.15 crores worth of assets

With a team of one of the best equity and credit researchers, as well as investment managers, ITI AMC runs a unique investment philosophy and strategies that are well-positioned to generate returns in the long-run. Being the latest entrant allows the AMC to offer products that can help investors benefit from our evolving economy.

Should I Invest in ITI Pharma & Healthcare Fund?

Investment Considerations:

Positive Factors:

- Strong Returns: ITI Pharma and Healthcare Fund Direct - Growth scheme return performance in last 1 year is 17.56%, in last 3 years is 103.73% and 79.68% since scheme launch

- Professional Management: Experienced fund management team with proven track record

- Growing Sector: Healthcare and pharmaceutical industry offers long-term growth potential

- Accessibility: Low minimum investment requirements for both SIP and lumpsum

Risk Factors:

- Sectoral Concentration: We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one

- High Risk Rating: The ITI Pharma and Healthcare Fund Direct Growth is rated Very High risk

- Investment Horizon: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years

Key Charges:

- Expense Ratio (Direct Plan): 0.47 as of 11th April 2025

- Exit Load: 0.50%, if redeemed within 3 months

This fund is suitable for investors with high risk tolerance and long-term investment horizon who want exposure to the pharmaceutical and healthcare sector.

FAQs

What is today's NAV of ITI Pharma & Healthcare Fund?

The latest NAV declared is ₹17.978 as on 07 Jul 2025. NAV is updated daily and reflects the per-unit value of the fund.

What is the AUM of ITI Pharma & Healthcare Fund?

It has an AUM of ₹220.85 Crores as of July 2025. AUM represents the total market value of assets managed by the fund.

What is the expense ratio of ITI Pharma & Healthcare Fund?

The expense ratio of ITI Pharma & Healthcare Fund Plan is 0.47 as of 11th April 2025 for the direct plan, which covers fund management and operational costs.

What are the returns of ITI Pharma & Healthcare Fund since inception?

79.68% since scheme launch. The fund has delivered strong performance since its inception in 2018.

What is the minimum SIP amount to invest in ITI Pharma & Healthcare Fund?

The min. SIP amount to invest in this scheme is ₹500. This makes it accessible for regular monthly investments.

How do I invest in ITI Pharma & Healthcare Fund?

You can invest through Allvest by logging into your account, searching for the fund, and choosing between SIP or lumpsum investment options. Complete KYC is required before investing.

How to start a SIP in ITI Pharma & Healthcare Fund?

Through Allvest, select the SIP option, choose your monthly investment amount (minimum ₹500), set your preferred SIP date, and authorize auto-debit from your bank account.

How do I automate an SIP in ITI Pharma & Healthcare Fund?

Allvest provides auto-invest features where you can set up automatic monthly investments. Once configured, your chosen amount will be invested automatically on the selected date.

How can I withdraw/redeem my investment in ITI Pharma & Healthcare Fund?

You can redeem your investment through Allvest by accessing your portfolio, selecting the fund, and choosing partial or full redemption. Note the exit load charges if redeeming within 3 months.